Innovations
"Innovation" is Pulnovo Medical's motivation of exploring PADN technology in the treatment of pulmonary hypertension. For years, PADN technology and radiofrequency ablation technology are foundation of Pulnovo Medical. Through independent innovations, we have obtained national invention patents, with PCT international patents in over 40 countries, including Japan, Russia, South Korea, Singapore, New Zealand, Australia, India, Brazil, Canada and the European Union, as well as methodological patents in the United States.
Innovations
"Innovation" is Pulnovo Medical's motivation of exploring PADN technology in the treatment of pulmonary hypertension. For years, PADN technology and radiofrequency ablation technology are foundation of Pulnovo Medical. Through independent innovations, we have obtained national invention patents, with PCT international patents in over 40 countries, including Japan, Russia, South Korea, Singapore, New Zealand, Australia, India, Brazil, Canada and the European Union, as well as methodological patents in the United States.
Data @ Pulnovo
Investor Relations
Milestones
2022
May
Establish Pulmonary Hypertension Care Alliance with CDQI
June
Rated as "Top100 Medical Device Companies "
Rated as “TOP10 Best-Performing Companies in Value field for Minimally Invasive Intervention”
Rated as “Top 50 Innovative Biotech Companies”
Dr. Krishna Sudhir Joins Scientific Advisory Board
2021
Feb
PADN ® has been granted designation as a FDA Breakthrough Device
June
PADN-CFDA clinical trial, the world’s first pulmonary hypertension treatment device RCT study, has completed all patients enrollment
Aug
Succesfully raised millions of dollars through OrbiMed Healthcare Fund Management, Cenova Capital, Lilly Asia Ventures(LAV), and GaoRong
Sep
Shanghai office opened
Expanded wuxi office
Passed MDR CE Certification
Nov
In TCT, Prof. Gregg W. Stone announced that he will lead the global PADN multicenter clinical trial
dec
PADN-CFDA clinical trial carried out all patients' follow-ups
2020
May
Started research and development of the cold salt water instrument system for the control circle
2019
Nov
Obtained the Japanese Invention Patent
Jun
Obtained the Russian Invention Patent
Mar
Obtained the European Invention Patent
2018
Jun
Became the Key Medical Device Project in Wuxi City
Jan
Carried out multi-center, randomized, blinded, sham operation clinical trials and completed the first case enrollment
2017
Dec
Pulmonary hypertension interventional products obtained the National Innovative Medical Device approval
Sept
Obtained TÜV SÜD South Germany ISO13485 system certification
Mar
Obtained the PADN ® series product registration inspection report
2016
Dec
Obtained the Japanese Invention Patent
Jul
Obtained the Korean Invention Patent
Jun
Obtained the Russian Invention Patent
2015
Dec
Obtained the China National Invention Patent
Oct
Completed the detailed design of special interventions for pulmonary hypertension and achieved the ground-breaking breakthrough
Jan
Established and operated a quality management system in accordance with YY 0287/ISO 13485
2014
Jul
Reconstruction and expansion of Wuxi 10,000-grade clean production base complete
2013
Sept
Founded
Copyright © 2020  Pulnovo Medical    苏ICP备2020058805号